KZR - Financial Reports List - Kezar Life Sciences, Inc. - IntrinsicAlpha

Kezar Life Sciences, Inc. KZR

Healthcare - Biotechnology - NASDAQ - US

$ 4.01

-2.43 %

$ 29.3 M

Market Cap

-0.37

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	100.00%	37.33%	24.08%
Annual Report	FY	10-K	2024-12-31	0.00%	17.80%	13.90%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	12.08%	14.02%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	11.36%	12.70%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-6.98%	3.32%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-97.57%	-41.77%
Annual Report	FY	10-K	2023-12-31	0.00%	-55.96%	-47.88%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-37.79%	-34.87%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-50.17%	-64.09%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-25.19%	-54.45%

1